CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,000 | -98.0% | 1,000 | -94.1% | 0.00% | – |
| Q3 2021 | $102,000 | +142.9% | 17,048 | +0.0% | 0.00% | – |
| Q1 2021 | $42,000 | – | 17,045 | +1704400.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | -80.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
| Q2 2019 | $35,000 | +191.7% | 36,378 | +334.5% | 0.00% | – |
| Q1 2019 | $12,000 | +300.0% | 8,372 | +162.8% | 0.00% | – |
| Q4 2018 | $3,000 | -97.5% | 3,186 | -84.0% | 0.00% | – |
| Q3 2018 | $122,000 | +74.3% | 19,904 | +205.6% | 0.00% | – |
| Q2 2018 | $70,000 | -14.6% | 6,514 | -14.9% | 0.00% | – |
| Q1 2018 | $82,000 | +241.7% | 7,655 | +125.2% | 0.00% | – |
| Q4 2017 | $24,000 | +500.0% | 3,399 | +609.6% | 0.00% | – |
| Q3 2017 | $4,000 | +300.0% | 479 | +178.5% | 0.00% | – |
| Q2 2017 | $1,000 | -66.7% | 172 | -56.5% | 0.00% | – |
| Q1 2017 | $3,000 | -90.9% | 395 | -89.6% | 0.00% | – |
| Q4 2016 | $33,000 | – | 3,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |